Evidence map›Paper›PMID 42649856›Full record

ArticleCancers2026

Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer.

Nahuel Paesano, Violeta Catalá, Juan Camean, Tomás Eduardo Olmedo, Joaquín Ignacio Gurovich, Maximiliano Ringa, Berta Miró, Lucas Regis, Olga Mendez, Enrique Trilla and 1 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nahuel PaesanoUro-Radiology Unit, Clínica Creu Blanca, 08034 Barcelona, Spain.
Violeta CataláUro-Radiology Unit, Clínica Creu Blanca, 08034 Barcelona, Spain.
Juan CameanDepartment of Surgical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Tomás Eduardo OlmedoDepartment of Urology, Hospital Clínico Universidad de Chile, Independencia, Santiago 8380456, Chile.
Joaquín Ignacio GurovichDepartment of Urology, Hospital Clínico Universidad de Chile, Independencia, Santiago 8380456, Chile.
Maximiliano RingaDepartment of Urology, Hospital Alemán, Buenos Aires 1424, Argentina.
Berta MiróBioinformatics and Statistical Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.ORCID 0000-0001-6049-8697
Lucas RegisResearch Group in Urology, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Olga MendezResearch Group in Urology, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Enrique TrillaResearch Group in Urology, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Juan MoroteResearch Group in Urology, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.

Funding

Instituto de Salut Carlos III PI23/01310
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinically significant prostate cancermagnetic resonance imagingpredictive model

Identifiers

PMID42649856
PMCPMC13511617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.